INR self-management permits lower anticoagulation levels after mechanical heart valve replacement

Circulation

Volumn 108, Issue 10 SUPPL., 2003, Pages

  Koertke, H ^a,g   Minami, K ^a   Boethig, D ^a   Breymann, Th ^a   Seifert, D ^a   Wagner, O ^a   Atmacha, N ^b   Krian, A ^b   Ennker, J ^c   Taborski, U ^d   Klovekorn W P ^d   Moosdorf, R ^e   Saggau, W ^f   Koerfer, R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Evangelisches/Johanniter Klinikum   (Germany)

^c Heart Institute Lahr/Baden   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f KLINIKUM LUDWIGSHAFEN   (Germany)

^g RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Anticoagulation; Heart valve replacement; INR self management; Low dose anticoagulation

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MANAGEMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM;

ANTICOAGULANTS; AORTIC VALVE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; SELF CARE; THROMBOEMBOLISM;

EID: 0042917969     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Roberts WC. Choosing a substitute cardiac valve; type, size, surgeon. Am J Cardiol. 1976;38:633-636.
2. Hammermeister KE, Gulshan S, William G, Oprian C, Tai K, Shahbudin R. A comparison of outcomes in men 11 years after heart valve replacement with a mechanical or bioprosthesis. N Engl J Med. 1993;328:1289-1296.
3. Koertke H, Koerfer R. International Standardized Ratio self management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001;72:44-48.
4. , Edmunds LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg. 1987;44:430-445.
5. Forfar JC. A 7-year analysis of hemorrhage in patients on long-term anticoagulant therapy. Br Heart J. 1979;42:128-132.
6. Gaudel G, Fourchard J. Complications du traitment anticoagulant; a propos de 98 accidents et incidents. Sem Hop Paris. 1979;55:1340-1345.
7. Halhuber C. Quickwert-Selbstbestimmung durch den Patienten nach Herzklappenersatz. Herz + Gefaesse. 1987;7:240-246.
8. Davies FB, Estruch MT, Samson-Corvera EB, Voigt GC, Tobin JD. Management of anticoagulation in outpatients, experience with an anticoagulation service in a municipal hospital setting. Arch Intern Med. 1977;137:197-202.
9. Husted S, Andreasen F. Problems encountered in long-term treatment with anticoagulants. Acta Med Scand. 1976;200:379-384.
10. Second report of the Sixty Plus Reinfarction Study Research Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet. 1982;Jan 9(8263):64-68.
11. Butchart EG. Prosthesis-specific and patient-specific anticoagulation. In: Butchart EG, Bodnar E, eds. Thrombosis, Embolism and Bleeding. London: ICR Publishers; 1992:293-317.
12. Kalmar P, Irrgang E. Cardiac surgery in Germany during 2001: A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2002;50:30-35.
13. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Symposium held at New York Academy of Medicine. Columbia: University Press, 1949:191-205.
14. Witts J, Beesar H, Lang H, et al. Thromboplastin und INR Standortbestimmung, J Lab Med. 20:443-449.
15. Kulinna W, Ney D, Wenzel T et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost. 1999;25:123-126.
16. Stein PD, Albert JS, Copeland J, Dalen JE, Goldmann S, Turpie AGG. Antithrombotic therapy in patients with mechanic and biological heart valves. Chest. 1995;108(4 Suppl):S371-379.
17. White RH, McCurdy SA, von Marensdorff H, et al. Home Prothrombin Time Monitoring after initiation of a Warfarin Therapy, Ann Int Med. 1989;111:730-737.